Business
Official Opening of the Charles Centre for Dermatology at UL Hospital
Official Opening of the Charles Centre for Dermatology at UL Hospital; Consultant dermatologist, Dr Bart Ramsey, in discussion about confocal microscopy, with CEO Colette Cowan Picture: Brian Arthur
A new specialist skin treatment unit, the Charles Centre for Dermatology, has officially been opened at University Hospital Limerick, following the construction of the €16.5m Leben building and major investment by JP McManus.
The Charles Centre for Dermatology, occupying the fifth floor of the Leben building, is the first of its kind in the Mid-West following a €2.2m boost from the JP McManus Invitational Pro-Am.
The magnificent Leben building comprises a 24-bed neurology/stroke unit, a nine-bed cystic fibrosis adult inpatient unit, an outpatient cystic fibrosis unit, a dermatology unit, and a symptomatic breast unit
The new facility will allow for up to 12,000 outpatient appointments each year.
Consultant dermatologist Dr Bart Ramsay, UL Hospitals Group, said that only patients who “suffer from skin disease of skin cancer can really understand the impact their condition has on them”.
“The dermatology patients appreciate its beauty, its sense of spaciousness and calmness as well as the kindness and care they are receiving. The dermatology staff are taking great joy from seeing the positive impact the unit is having on patients.”
UL Hospitals Group chairperson, Professor Niall O’Higgins described the development of the incredible facility over the past five years has been “astonishing”.
UL Hospitals Group CEO, Colette Cowan described it as an appropriate development at UHL, following a 132% increase in new referrals in dermatology services.
Mid-Western Hospitals Development Trust chairperson, Jim Canny said that the new centre will offer “a first-class service for patients suffering from conditions”.
It is named after the Charles family, who are the founders of the City of Dublin Skin and Cancer Hospital.
To find out more about the Leben building, you can click here.
To find out more about JP McManus’ major investment, please click here.
To read more stories about UHL, you can click here.